Proceedings: Uptake of 67gallium by normal lactating mammary gland and by tumours in the dog. by Yoxall, A. T. & Owen, L. N.
ABSTRACTS OF MEMBERS PAPERS 247
ing Co. 1970), between 30 and 40% had
objective remissions.
Pre-treatment levels of prolactin were
variable, and were not changed by treatment,
whether or not remission occurred. Pre-
treatment levels of oestradiol varied less, but
were also substantially unchanged in all
patients during treatment. Growth hor-
mone showed no consistent response. In
most patients in whom regression of disease
was observed, values of luteinizing and
follicle stimulating hormone did not vary, but
in the majority ofnon-responders, gonadotro-
phin levels were lowered.
METABOLIC ABNORMALITIES IN
TUMOUR BEARING ANIMALS. K. C.
CALMAN and R. A. McALLISTER, Department
of Clinical Oncology, Western Infirmary,
Glasgow.
Twenty-four hours after implantation of
the TLX-5 lymphoma in CBA mice, the CoA
content of liver was significantly reduced
(P < 0-001). Significant reductions in the
CoA content continued up to the seventh day,
when the animals were in a moribund state.
The citrate content of liver showed no further
significant increases until the seventh day.
Significant reductions in energy content
(ATP, ADP, AMP) of these livers did not
occur until 6 days after implantation.
Control experiments in which normal CBA
mice were challenged with i.p. injections of
normal CBA spleen cells, or with spleen cells
from A strain mice, showed no change in the
CoA or citrate content of liver. No decrease
in CoA was noted in starvation experiments.
These results indicate that serious meta-
bolic abnormalities occur in the non-involved
organs of tumour bearing animals and these
may be related to the development of
cachexia.
UPTAKE OF 67GALLIUM BY NORMAL
LACTATING MAMMARY GLAND AND
BY TUMOURS IN THE DOG. A. T.
YOXALL and L. N. OWEN, Department of
Clinical Veterinary Medicine, University of
Cambridge.
Following intravenous injection of 67Ga
it is known that there is a concentration of
the isotope in several tumours and in a few
normal tumours, including lactating mam-
mary gland. Investigations in the lactating
bitch have shown that 67Ga and 45Ca were
taken up by the mammary tissue at the same
rate and that the isotopes reached similar
levels in both plasma and milk. The isotopes
were found to be associated with calcium
binding proteins in milk. It was not
possible to show any correlation between
67Ga and 45Ca uptake in a transmissible
venereal tumour.
A preliminary study to investigate ifthere
is any association between the " leakiness "
oftumour blood vessels as determined by the
uptake of 1251-albumin and 67Ga in a
melanoma has produced equivocal results.
THE PROGNOSIS FOLLOWING SUR-
GICAL EXCISION OF CANINE MAM-
MARY CARCINOMATA. D. E. Bos-
TOCK, Department of Clinical Veterinary
Medicine, University of Cambridge.
Spontaneously arising canine mammary
carcinomata may be of value as models in
immunotherapeutic trials for breast cancer in
women, but before their full potential can be
exploited their behaviour following surgery
alone must be known.
For this reason, 227 bitches from which
histologically confirmed mammary carcino-
mata had been excised were followed up.
Only 43% of these animals were eventually
destroyed as a result of the original tumour
but the accuracy of the prognosis could be
improved by histologically sub-dividing the
tumours. Papillary and tubular adeno-
carcinomata carried the most favourable
prognosis, the median survival times being 12
and 90 weeks. Dogs with solid carcinomata
had a medial post surgical survival time of44
weeks whereas for those with anaplastic
carcinoma it was only 11 weeks. Clinical
immunotherapeutic trials will thus be con-
centrated on dogs with the latter tumour
types.
Since most dogs die from their tumour
within 12 months of surgery it should be
possible to evaluate the effect ofpost surgical
immunotherapy sooner than would be
possible with a similar trial in man.
AUTORADIOGRAPHY OF EHRLICH
ASCITES TUMOURS TREATED WITH
SOYBEAN TRYPSIN INHIBITOR IN
VIVO. P. WHUR and H. KOPPEL, Cell
Biology Unit, Marie Curie Memorial Found-
ation, Oxted and B. WEATHERHEAD, Depart-